自膨式 ACURATE neo2 瓣膜再次经导管主动脉瓣置换术的可行性:一项 CT 研究。

Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study.

机构信息

The Heart Center, Rigshospitalet, Copenhagen, Denmark.

Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust London, London, United Kingdom.

出版信息

EuroIntervention. 2024 Nov 18;20(22):1405-1415. doi: 10.4244/EIJ-D-24-00367.

Abstract

BACKGROUND

Redo-transcatheter aortic valve implantation (TAVI) may be unfeasible because of the risk of compromising coronary flow or coronary access by the pinned back leaflets of the index transcatheter aortic valve.

AIMS

We aimed to evaluate the feasibility of redo-TAVI using the balloon-expandable SAPIEN 3 (S3) implanted within the self-expanding ACURATE neo2 (ACn2) valve and to identify predictors associated with a high risk of compromising coronary flow.

METHODS

A total of 153 post-ACn2 TAVI cardiac computed tomography scans were analysed. Redo-TAVI using an S3 was simulated in two positions: S3 outflow to the ACn2 upper crown (low implant) and S3 outflow to the base of the ACn2 commissural posts (high implant). The risk for coronary flow compromise and inaccessibility was determined by the height of the neoskirt created by the pinned back leaflets and the valve-to-aorta distances.

RESULTS

At a low S3 implant position, risk of coronary flow compromise was predicted in only 8% of patients and this increased to 60% with a high S3 position. In accordance, coronary access was predicted to be unrestricted in 52% versus 13% of patients with a low versus high S3 implantation. Female sex, a small aortic annular dimension and a sinotubular junction-to-aortic annulus mean diameter ratio <1.15 were independent predictors associated with a high risk for coronary flow compromise.

CONCLUSIONS

The feasibility of redo-TAVI with an S3 in an ACn2 depends on the implant depth of the S3 and the geometry of the surrounding aorta. A low S3 implant may reduce the risk of coronary flow compromise and inaccessibility.

摘要

背景

由于先前经导管主动脉瓣置换术(TAVI)植入的瓣叶向后卷曲,可能会影响冠状动脉血流或冠状动脉入路,因此再次行经导管主动脉瓣置换术(redo-TAVI)可能无法实施。

目的

我们旨在评估在自膨式 ACURATE neo2(ACn2)瓣内植入球囊扩张式 SAPIEN 3(S3)行 redo-TAVI 的可行性,并确定与冠状动脉血流受损风险相关的预测因素。

方法

共分析了 153 例 ACn2 后 TAVI 心脏计算机断层扫描(CT)。在两种位置模拟了使用 S3 行 redo-TAVI:S3 流出至 ACn2 上冠(低位植入)和 S3 流出至 ACn2 瓣叶连合部支柱底部(高位植入)。通过后瓣叶向后卷曲形成的新裙边高度和瓣叶-主动脉距离来确定冠状动脉血流受损和不可接近的风险。

结果

在 S3 低位植入时,仅预测到 8%的患者存在冠状动脉血流受损风险,而 S3 高位植入时该风险增加至 60%。相应地,预测冠状动脉可接近的患者比例在 S3 低位植入时为 52%,而在 S3 高位植入时为 13%。女性、主动脉瓣环较小以及窦管交界-主动脉瓣环平均直径比<1.15 是与冠状动脉血流受损风险相关的独立预测因素。

结论

在 ACn2 内植入 S3 行 redo-TAVI 的可行性取决于 S3 的植入深度和周围主动脉的几何形状。S3 低位植入可能会降低冠状动脉血流受损和不可接近的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索